You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of Medicines. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.
In 2023, Medicines received 233 review reports, from 226 reviewers. This past year, we worked with reviewers from 56 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the Medicines family throughout 2023, and we look forward to their continued support in 2024.
The following are the reviewers who have consented to show their names:
Alexander Tamalunas | Lainie Cameron |
Alexandra Filippopoulou | Maria Wostrack |
Alexis Murillo Carrasco | Mariya Smetanina |
Amir Faisal | Maryam Poursadeghfard |
Ana Ledesma | Masoud Sadeghi |
Andreea Moga | Megan L. Falsetta |
Andrej Belančić | Mickaël Bobot |
Andrzej Konieczny | Mohamed Lounis |
Antonio Franco | Mohammad Al-Wardat |
Beatrice Bretherton | Muhammad Latif |
Berenika Szczęśniak-Sięga | Naina Mohamed Maideen |
Cheryl Beseler | Natalia Rivera |
Claudia Ferraris | Nazario Foschi |
Danijela Cvetković | Neda Milevska Kostova |
Diana Rodríguez-Hurtado | Norhafiza Mat Lazim |
Ekaterina A. Narodova | Patrícia Pires |
Elena Kotenkova | Pinaki Bhattacharjee |
Ewa Rychlik | Plamen Todorov |
Farhan Siddique | Raja Singh Paulraj |
Fouzia Munir | Renars Erts |
Gabriel Gutiérrez-Ospina | Ritthideach Yorsaeng |
Gheorghe-Emilian Olteanu | Rukang Zhang |
Graeme Hoddinott | Salvatore Allosso |
Gulali Aktas | Samit Ghosh |
Ighli di Bari | Sebastiano Cicco |
Ioan Florin Marchis | Sharat Chandra |
Ioana Marin | Slaven Falamić |
Iulian Sarbu | Surya Nirmal |
Jarosław Walory | Thong Ba Nguyen |
Jing Ma | Tom Huxford |
Johannes Wach | Unaib Rabbani |
Johnny Ionut Efanov | Vera Larina |
Jose Manuel Cancio-Trujillo | Vibhav Gautam |
Katarzyna Rolf | Wan-Ju Annabelle Lee |
Katsusuke Ozawa | Xiaobo Wu |
Kevin Fuji | Yoong Soon Yong |
Koichi Taira |